DUBLIN, Oct. 28, 2020 /PRNewswire/ -- The "Global Population Sequencing Market: Focus on Product, Method, Technology, Application, Country, and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
Growth in this market is expected to be driven by the rising adoption of large-scale sequencing to understand the genomics of susceptibility and resistance from COVID-19, increasing adoption of personalized medicine for the screening and diagnosis of genetic disorders, and a global surge in direct-to-consumer genetic testing.
However, there are significant challenges that are restraining the market growth, such as lack of infrastructure to maintain, store, and share sensitive genomic data, absence of sufficient funding for the development of high-throughput genomic software tools, and poor reducibility and transability of data in clinical practice.
The market is favored by the technological advancements in the sequencing, and computational analysis solutions for a large volume of genetic data enabling a deep understanding of the genetic variants for the development of diagnostics, drug discovery, and translational research.
Furthermore, several sequencing companies are focusing on the development of high-throughput sequence platforms and polymerase chain reaction platforms, with higher sensitivity and low turn-around time to benefit the patients, enabling patient-based outcomes and implementing genomic medicine.
Within the research report, the market is segmented on the basis of product type, application, methods, and technology. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of rapid diagnostics providing information on genetic mutation and optimal candidates for adjuvant chemotherapy or hormonal therapy. Due to the diverse product portfolio and intense market penetration, Illumina, Inc. has been a pioneer in this field and has been a significant competitor in this market.
The population sequencing market provided immense growth opportunities for the companies providing technology and infrastructure for large-scale health initiatives, such as Color Genomics, Inc., Helix Opco, LLC, and big data companies such as Genuity Science.
Key Questions Answered in this Report:
- What are the major market drivers, challenges, and opportunities in the global population sequencing market?
- What is the potential impact of sequencing and biotechnological advancement in the application of genomic medicine and translational research?
- What is the current market expense along with future expected expenses in population sequencing initiatives?
- How population sequencing helped genomic tests to become a prominent tool for diagnostics in various clinical applications?
- What are the key development strategies which are implemented by the major players in order to sustain in the competitive market?
- How is each segment of the market expected to grow during the forecast period from 2020 to 2030 based on:
- product type
- Who are the leading players with significant offerings to the global population sequencing market? What is the expected market dominance for each of these leading players?
- Which emerging companies are anticipated to be highly disruptive in the future, and what are their key strategies for sustainable growth in the population sequencing industry?
Key Topics Covered:
1 Product Definition
1.1 Definition by Product
1.1.2 Kits and Assays
1.1.3 Software Tools
1.2 Inclusion and Exclusion
1.2.1 Inclusion and Exclusion for Country-Wise Market Estimation
1.3 Scope of Work
1.4 Key Questions Answered in the Report
2 Research Methodology
3.1 Market Overview
3.2 Impact of COVID-19 on Population Sequencing
3.3 Future Potential
4 Global Population Sequencing Market Dynamics
4.2 Impact Analysis
4.3 Market Drivers
4.3.1 Rising Adoption of Large-Scale Sequencing to Understand the Genomics of Susceptibility and Resistance from COVID-19
4.3.2 Increasing Adoption of Personalized Medicine for the Screening and Diagnostics of Genetic Disorders
4.3.3 Global Surge in Direct-to-Consumer (DTC) Genetic Testing
4.4 Market Restraints
4.4.1 Lack of Infrastructure to Maintain, Store and Share Sensitive Genomic Data
4.4.2 Absence of Sufficient Funding for Development of High-Throughput Genomic Software Tools
4.4.3 Poor Reducibility and Translatability of Data in Clinical Practice
4.5 Market Opportunity
4.5.1 Advancing Precision Medicine with Blockchain-Powered Artificial Intelligence
4.5.2 Technological Advancements in Sample Preparation for Population Sequencing
4.5.3 Increased Population Engagement and Data Management
5 Competitive Landscape
5.1 Key Strategies and Developments
5.1.1 Product Approval
5.1.2 Product Launches and Upgradations
5.1.3 Synergistic Activities
5.1.4 Funding and Expansion
6 Industry Insights
6.2 Legal Requirements and Framework in the U.S.
6.3 Legal Requirements and Framework in Europe
6.4 Legal Requirements and Framework in Asia-Pacific
6.5 Market Share Analysis (by Company) 2019
6.5.1 Growth Share Analysis (Opportunity Mapping)
6.5.2 By Company
7 Global Population Sequencing Initiatives (by Country)
8 Global Population Sequencing Market (by Product), $Million, 2019-2030
8.2 Kits and Assays
8.4 Software Tools
9 Global Population Sequencing Market (by Methods), $Million, 2019-2030
9.2 Whole Genome Sequencing
9.3 Whole Exome Sequencing
9.4 Single-Read Sequencing
9.5 Other Sequencing Methods
10 Global Population Sequencing Market (by Technology), $Million, 2019-2030
10.2 Polymerase Chain Reaction (PCR)
10.3 Next Generation Sequencing (NGS)
10.4 Other Technologies
11 Global Population Sequencing Market (by Application), $Million, 2019-2030
11.2 Human health
11.2.1 Clinical Applications
22.214.171.124.1 Cancer Diagnostics
126.96.36.199.2 Infectious Disease Diagnostics
188.8.131.52.3 Rare Disease Diagnostics
184.108.40.206.4 Other Diagnostics
220.127.116.11 Drug Discovery and Development
11.2.2 Translational Research Sequencing
11.3 Molecular Forensics
11.4 Blockchain in Genomics
11.4.1 Data Sharing and Monetization
11.4.2 Data Storage and Security
11.4.3 Automated Health Insurance
12 Global Population Sequencing Market (by Country), $Million, 2019-2030
13 Company Profiles
13.1 Company Overview
13.2 Role of Agilent Technologies, Inc. in Global Population Sequencing Market
13.4 Key Insights About Financial Health of the Company
13.5 SWOT Analysis
- Agilent Technologies, Inc.
- Beijing Genomics Institute (BGI)
- Color Genomics, Inc.
- F. Hoffmann-La Roche Ltd
- Genuity Science
- Helix OpCo, LLC
- Illumina, Inc.
- Nebula Genomics, Inc.
- Oxford Nanopore Technologies, Inc.
- Pacific Biosciences of California, Inc.
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/aqpxxy
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets